Bullous Myringitis (BM) is a pathological condition characterised by the formation of painful blisters on the tympanic membrane, leading to challenges in its management. The present study investigated the effectiveness of BM treatment, the potential risks associated with surgical interventions, and the efficacy of topical therapy. The study consisted of a retrospective cohort analysis spanning a period of five years, involving a total of 50 patients diagnosed with Bullous Myringitis. The study encompassed an examination of various aspects, including demographics, symptoms, treatments, and outcomes. The efficacy of topical treatments was evaluated through a randomised controlled trial (RCT). The application of linear regression was employed in order to ascertain the predictors of treatment outcomes. The present study investigated the participants' quality of life and the occurrence of complications. The most commonly reported complaint, ear pain, demonstrated the greatest efficacy when treated with topical medication. The randomised controlled trial (RCT) demonstrated that the implementation of topical treatment resulted in a notable amelioration of symptoms and an increase in patient satisfaction. The treatment modality was found to be a significant predictor of positive outcomes, while no significant associations were observed between age and gender and treatment outcomes. The application of topical therapy resulted in a decrease in the occurrence of granular myringitis and a reduction in sensorineural hearing loss. The patients indicated an enhancement in their quality of life subsequent to the intervention. Personalised therapeutic strategies, surgical prudence, and topical therapies play a crucial role in the management of BM. This study presents a comprehensive framework for the implementation of evidence-based procedures related to bowel movements. In order to validate these findings, it is recommended that comprehensive, prospective studies be conducted on a large scale.
4 February 2023 in Indian Journal of Otolaryngology and Head & Neck Surgery
Background: The existing association between hearing impairment and diabetes mellitus (DM) prompted us to investigate the relationship between glycaemic control, as measured by HbA1c levels, and hearing impairment in individuals with type 2 diabetes mellitus (T2DM). Methods: In this study, we assessed the auditory function of a sample of 100 individuals diagnosed with T2DM, who were aged 30 years or older and had a disease duration of at least 5 years. The evaluation was conducted using distortion product otoacoustic emissions and transient evoked otoacoustic emissions. The criteria for poor glycaemic control were established as HbA1c levels equal to or exceeding 7.5%. Results: Individuals with a haemoglobin A1c (HbA1c) level of 7.5% or higher exhibited a nearly threefold increased likelihood of developing hearing impairment in comparison to those with lower HbA1c levels. The gender-based observation revealed a stronger association in females, although the observed correlation did not reach statistical significance. Conclusions: The findings of our study establish a significant association between inadequate management of blood glucose levels and the occurrence of hearing impairment among individuals with T2DM. These results underscore the importance of achieving optimal glycaemic control as a means of preventing hearing impairment in this patient population. Further investigation is required to substantiate these findings through a comprehensive and longitudinal research approach.